During the past decade, National Hospital Organization Nagoya Medical Center conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 25 clinical trials were completed, i.e. on average, 46.3% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 17 clinical trials were completed. i.e. 54.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Nagoya Medical Center" #1 sponsor was "Pfizer" with 10 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Celgene" with 7 trials sponsored, "Loxo Oncology, Inc." with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Nagoya Medical Center" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Nagoya Medical Center" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Rheumatoid Arthritis" (4 trials), "Small Lymphocytic Lymphoma" (4 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "National Hospital Organization Nagoya Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Nagoya Medical Center" are "Drug" (78 trials), "Biological" (7 trials), "Other" (5 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Pemetrexed" (7 trials), "Carboplatin" (5 trials), "Rituximab" (5 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Nagoya Medical Center" are 84 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Hospital Organization Nagoya Medical Center". undefined are not yet recruiting, 17 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in National Hospital Organization Nagoya Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Nagoya Medical Center, 15 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".